Merck To Present New Data From Its Broad Oncology Portfolio and Pipeline at ESMO 2021, Including in Earlier Stages of Cancer Pharmaceutical Investing
Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Upcoming Healthcare Conferences Pharmaceutical Investing
Bristol Myers Squibb to Take Part in Morgan Stanley 19th Annual Global Healthcare Conference Biotech Investing
Merck's KEYTRUDA® Approved in China in Combination With Chemotherapy for First-Line Treatment of Patients With Locally Advanced Unresectable or Metastatic Esophageal or Gastroesophageal Junction Carcinoma Pharmaceutical Investing
Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC Medical Device Investing
Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus Pharmaceutical Investing
